Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248793 | 8308685 | F | 8248793-X | 20110719 | 20120329 | 20120331 | EXP | PHEH2011US012217 | NOVARTIS PHARMACEUTICAL CORPORATION | 53 | YR | F | Y | 20120330 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248793 | 1019282911 | PS | GILENYA | 1 | ORAL | 0.5 MG, QD | 022527 | ||||
| 8248793 | 1019282915 | C | CYMBALTA | 1 | ORAL | 60 UKN, QD | |||||
| 8248793 | 1019282913 | C | BENAZEPRIL HYDROCHLORIDE | 1 | ORAL | 20 UKN, QD | |||||
| 8248793 | 1019282914 | C | ASPIRIN | 1 | ORAL | 81 UKN, QD | |||||
| 8248793 | 1019282912 | C | PROTONIX | 1 | ORAL | 40 UKN, QD |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8248793 | 1019282911 | MULTIPLE SCLEROSIS |
| 8248793 | 1019282915 | DEPRESSION |
| 8248793 | 1019282913 | HYPERTENSION |
| 8248793 | 1019282914 | CARDIAC DISORDER |
| 8248793 | 1019282912 | GASTROOESOPHAGEAL REFLUX DISEASE |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8248793 | LT |
| 8248793 | OT |
| 8248793 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8248793 | PHOTOPSIA |
| 8248793 | CONVULSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8248793 | 1019282911 | 20110707 | 20111215 | 162 | DAY |
| 8248793 | 1019282915 | 20111001 | |||
| 8248793 | 1019282913 | 20080101 | |||
| 8248793 | 1019282914 | 20080101 | |||
| 8248793 | 1019282912 | 20100101 |